Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Vahid Rezaei, Amir Rabiee & Farzaneh Khademi. (2020) Glioblastoma multiforme: a glance at advanced therapies based on nanotechnology. Journal of Chemotherapy 32:3, pages 107-117.
Read now
Read now
Shoshy Mizrahy, Anna Gutkin, Paolo Decuzzi & Dan Peer. (2019) Targeting central nervous system pathologies with nanomedicines. Journal of Drug Targeting 27:5-6, pages 542-554.
Read now
Read now
Lakshmi Pallavi Ganipineni, Bernard Ucakar, Nicolas Joudiou, John Bianco, Pierre Danhier, Mengnan Zhao, Chiara Bastiancich, Bernard Gallez, Fabienne Danhier & Véronique Préat. (2018) Magnetic targeting of paclitaxel-loaded poly(lactic-co-glycolic acid)-based nanoparticles for the treatment of glioblastoma. International Journal of Nanomedicine 13, pages 4509-4521.
Read now
Read now
Articles from other publishers (38)
Yang Xing, Feroza Yasinjan, Mei Yang, Yajie Du, Huayue Geng, Minghua He, Yingtong Wang, Jicheng Sun, Wei Jiang, Ling Zhang, Baofeng Guo & Kelong Fan. (2023) A scientometric analysis and up-to-date review of nano-based drug delivery systems in glioblastoma treatment. Nano Today 52, pages 101961.
Crossref
Crossref
Rakesh Kumar Sahoo, Hitesh Kumar, Vikas Jain, Sonal Sinha, Ajazuddin & Umesh Gupta. (2023)
Angiopep-2 Grafted PAMAM Dendrimers for the Targeted Delivery of Temozolomide:
In Vitro
and
In Vivo
Effects of PEGylation in the Management of Glioblastoma Multiforme
. ACS Biomaterials Science & Engineering 9:7, pages 4288-4301.
Crossref
Crossref
Jia Guo, Zheng Yao, Feiyu Zhang & Junzi Wu. (2023) Application of Polymer Materials in Targeting Glioma. Anti-Cancer Agents in Medicinal Chemistry 23:11, pages 1284-1297.
Crossref
Crossref
Qiujun Qiu, Xinyi Ding, Jixiang Chen, Sunhui Chen & Jianxin Wang. (2023) Nanobiotechnology-based treatment strategies for malignant relapsed glioma. Journal of Controlled Release 358, pages 681-705.
Crossref
Crossref
Tanisha Gupta, Rakesh K. Sahoo, Himani Singh, Sumeet Katke, Akash Chaurasiya & Umesh Gupta. (2023) Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities. AAPS PharmSciTech 24:4.
Crossref
Crossref
Vishwanath Kurawattimath, Barnabas Wilson & Kannoth Mukundan Geetha. (2023) Nanoparticle-based drug delivery across the blood-brain barrier for treating malignant brain glioma. OpenNano 10, pages 100128.
Crossref
Crossref
Puja Sandbhor, Jayant Goda, Bhabani Mohanty, Poonam Gera, Sandhya Yadav, Godanjali Chekuri, Pradip Chaudhari, Shilpee Dutt & Rinti Banerjee. (2022) Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model. Drug Delivery and Translational Research 13:2, pages 608-626.
Crossref
Crossref
Zi-Hua Guo, Saadullah Khattak, Mohd Ahmar Rauf, Mohammad Azam Ansari, Mohammad N. Alomary, Sufyan Razak, Chang-Yong Yang, Dong-Dong Wu & Xin-Ying Ji. (2023) Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders. Molecules 28:3, pages 1283.
Crossref
Crossref
Mehboob Hoque, Arijit Samanta, Syed Sahajada Mahafujul Alam, Torki A. Zughaibi, Mohammad Amjad Kamal & Shams Tabrez. (2023) Nanomedicine-based immunotherapy for Alzheimer's disease. Neuroscience & Biobehavioral Reviews 144, pages 104973.
Crossref
Crossref
Qingchun Lei, Yongmin Yang, Wenhui Zhou, Wenwen Liu, Yixin Li, Nanchang Qi, Qiangfeng Li, Zhonghui Wen, Lei Ding, Xiaobin Huang, Yu Li & Jin Wu. (2023) MicroRNA-based therapy for glioblastoma: Opportunities and challenges. European Journal of Pharmacology 938, pages 175388.
Crossref
Crossref
Faraz Ahmad, Ressin Varghese, Subhrajita Panda, Siva Ramamoorthy, Mohammad Y. Areeshi, Sharmila Fagoonee & Shafiul Haque. (2022) Smart Nanoformulations for Brain Cancer Theranostics: Challenges and Promises. Cancers 14:21, pages 5389.
Crossref
Crossref
Yuanyuan Shen, Mengni Hu, Wen Li, Yiling Chen, Yiluo Xu, Litao Sun, Dongzhe Liu, Siping Chen, Yueqing Gu, Yi Ma & Xin Chen. (2022) Delivery of DNA octahedra enhanced by focused ultrasound with microbubbles for glioma therapy. Journal of Controlled Release 350, pages 158-174.
Crossref
Crossref
Michael Plaksin, Tiran Bercovici, Gabriella Gabi Sat Toltsis, Javier Grinfeld, Boaz Shapira, Yuval Zur, Rafi de Picciotto, Eyal Zadicario, Mustaffa Siddeeq, Anton Wohl, Zion Zibly, Yoav Levy & Zvi R. Cohen. (2022) Magnetic resonance imaging analysis predicts nanoparticle concentration delivered to the brain parenchyma. Communications Biology 5:1.
Crossref
Crossref
S. Daisy Precilla, Indrani Biswas, Shreyas S. Kuduvalli & T.S. Anitha. (2022) Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?. Cellular Signalling 95, pages 110350.
Crossref
Crossref
Jian Wang & Shumei Chi. (2022) Characterization of the Immune Cell Infiltration Landscape and a New Prognostic Score in Glioblastoma. Journal of Healthcare Engineering 2022, pages 1-9.
Crossref
Crossref
Ruiqi Li, Haihong Wang, Qing Liang, Lian Chen & Jinghua Ren. (2022) Radiotherapy for glioblastoma: clinical issues and nanotechnology strategies. Biomaterials Science 10:4, pages 892-908.
Crossref
Crossref
Ahmet Kaynak, Harold W. Davis, Subrahmanya D. Vallabhapurapu, Koon Y. Pak, Brian D. Gray & Xiaoyang Qi. (2021) SapC–DOPS as a Novel Therapeutic and Diagnostic Agent for Glioblastoma Therapy and Detection: Alternative to Old Drugs and Agents. Pharmaceuticals 14:11, pages 1193.
Crossref
Crossref
Elisabete Cruz Da Silva, Marie-Cécile Mercier, Nelly Etienne-Selloum, Monique Dontenwill & Laurence Choulier. (2021) A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials. Cancers 13:8, pages 1795.
Crossref
Crossref
Md. Habban Akhter, Md. Rizwanullah, Javed AhmadSaima Amin, Mohammad Zaki AhmadMd. Akram Minhaj, Md. Ali Mujtaba & Javed Ali. (2020) Molecular Targets and Nanoparticulate Systems Designed for the Improved Therapeutic Intervention in Glioblastoma Multiforme. Drug Research 71:03, pages 122-137.
Crossref
Crossref
Ganesh B. Shevalkar, Nisha R. Yadav, Chandrakantsing V. Pardeshi & Sanjay J. Surana. 2021. Advanced Drug Delivery Systems in the Management of Cancer. Advanced Drug Delivery Systems in the Management of Cancer
183
195
.
Daniel Rosenblum, Anna Gutkin, Ranit Kedmi, Srinivas RamishettiNuphar VeigaAshley M. Jacobi, Mollie S. Schubert, Dinorah Friedmann-Morvinski, Zvi R. CohenMark A. Behlke, Judy Lieberman & Dan Peer. (2020) CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy. Science Advances 6:47.
Crossref
Crossref
Panpan Song, Xia Zhao & Sa Xiao. (2020) Application prospect of peptide-modified nano targeting drug delivery system combined with PD-1/PD-L1 based immune checkpoint blockade in glioblastoma. International Journal of Pharmaceutics 589, pages 119865.
Crossref
Crossref
Sumaira Hanif, Pir Muhammad, Rose Chesworth, Fawad Ur Rehman, Rong-jun Qian, Meng Zheng & Bing-yang Shi. (2020) Nanomedicine-based immunotherapy for central nervous system disorders. Acta Pharmacologica Sinica 41:7, pages 936-953.
Crossref
Crossref
Irfan Ullah, Kunho Chung, Sumin Bae, Yan Li, Chunggu Kim, Boyoung Choi, Hye Yeong Nam, Sun Hwa Kim, Chae-Ok Yun, Kuen Yong Lee, Priti Kumar & Sang-Kyung Lee. (2020) Nose-to-Brain Delivery of Cancer-Targeting Paclitaxel-Loaded Nanoparticles Potentiates Antitumor Effects in Malignant Glioblastoma. Molecular Pharmaceutics 17:4, pages 1193-1204.
Crossref
Crossref
Hari Shanker Sharma, Dafin F. Muresanu, Ala Nozari, José Vicente Lafuente, Z. Ryan Tian, Seaab Sahib, Igor Bryukhovetskiy, Andrey Bryukhovetskiy, Anca D. Buzoianu, Ranjana Patnaik, Lars Wiklund & Aruna Sharma. 2020. Novel Therapeutic Advances in Glioblastoma. Novel Therapeutic Advances in Glioblastoma
1
66
.
Anna Gutkin & Dan Peer. (2018) Gene Silencing in the Right Place at the Right Time. Molecular Therapy 26:11, pages 2539-2541.
Crossref
Crossref
Caterina Brighi, Simon Puttick, Stephen Rose & Andrew K. Whittaker. (2018) The potential for remodelling the tumour vasculature in glioblastoma. Advanced Drug Delivery Reviews 136-137, pages 49-61.
Crossref
Crossref
Cataldo Arcuri, Lorenzo Monarca, Francesco Ragonese, Carmen Mecca, Stefano Bruscoli, Stefano Giovagnoli, Rosario Donato, Oxana Bereshchenko, Bernard Fioretti & Ferdinando Costantino. (2018) Probing Internalization Effects and Biocompatibility of Ultrasmall Zirconium Metal-Organic Frameworks UiO-66 NP in U251 Glioblastoma Cancer Cells. Nanomaterials 8:11, pages 867.
Crossref
Crossref
Lakshmi Pallavi Ganipineni, Fabienne Danhier & Véronique Préat. (2018) Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment. Journal of Controlled Release 281, pages 42-57.
Crossref
Crossref
L. Nam, C. Coll, L. Erthal, C. de la Torre, D. Serrano, R. Martínez-Máñez, M. Santos-Martínez & E. Ruiz-Hernández. (2018) Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme. Materials 11:5, pages 779.
Crossref
Crossref
Mariachiara Zuccarini, Patricia Giuliani, Sihana Ziberi, Marzia Carluccio, Patrizia Di Iorio, Francesco Caciagli & Renata Ciccarelli. (2018) The Role of Wnt Signal in Glioblastoma Development and Progression: A Possible New Pharmacological Target for the Therapy of This Tumor. Genes 9:2, pages 105.
Crossref
Crossref
Rui Pedro Moura, Andreia Almeida & Bruno Sarmento. (2017) The role of non-endothelial cells on the penetration of nanoparticles through the blood brain barrier. Progress in Neurobiology 159, pages 39-49.
Crossref
Crossref
Zhilan Chai, Xuefeng Hu, Xiaoli Wei, Changyou Zhan, Linwei Lu, Kuan Jiang, Bingxia Su, Huitong Ruan, Danni Ran, Ronnie H. Fang, Liangfang Zhang & Weiyue Lu. (2017) A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery. Journal of Controlled Release 264, pages 102-111.
Crossref
Crossref
John Bianco, Chiara Bastiancich, Aleksander Jankovski, Anne des Rieux, Véronique Préat & Fabienne Danhier. (2017) On glioblastoma and the search for a cure: where do we stand?. Cellular and Molecular Life Sciences 74:13, pages 2451-2466.
Crossref
Crossref
Konstantina Papadia, Eleni Markoutsa, Spyridon Mourtas, Anastassios D. Giannou, Barabara La Ferla, Fransesco Nicotra, Mario Salmona, Pavlos Klepetsanis, Georgios T. Stathopoulos & Sophia G. Antimisiaris. (2017) Multifunctional LUV liposomes decorated for BBB and amyloid targeting. A. In vitro proof-of-concept. European Journal of Pharmaceutical Sciences 101, pages 140-148.
Crossref
Crossref
Vivek Agrahari. (2017) The exciting potential of nanotherapy in brain-tumor targeted drug delivery approaches. Neural Regeneration Research 12:2, pages 197.
Crossref
Crossref
Wei Shi, Xuexue Cui, Jinlong Shi, Jian Chen & Yi Wang. (2017) Overcoming the blood–brain barrier for glioma-targeted therapy based on an interleukin-6 receptor-mediated micelle system. RSC Advances 7:44, pages 27162-27169.
Crossref
Crossref
Menghuan Li, Zhong Luo, Zhining Xia, Xinkun Shen & Kaiyong Cai. (2017) Time-sequenced drug delivery approaches towards effective chemotherapeutic treatment of glioma. Materials Horizons 4:6, pages 977-996.
Crossref
Crossref